Antinuclear antibodies and patterns of nuclear immunofluorescence in type 1 autoimmune hepatitis

Digestive Diseases and Sciences

Volumn 42, Issue 8, 1997, Pages 1688-1696

  Czaja, Albert J ^a   Cassani, Fabio ^b   Cataleta, Michela ^b   Valentini, Paolo ^b   Bianchi, Francesco B ^b  

^a MAYO CLINIC   (United States)

^b NONE

Author keywords

Antinuclear antibodies; Autoantibodies; Autoimmune hepatitis; Human leukocyte antigens

Indexed keywords

HLA DR3 ANTIGEN; HLA DR4 ANTIGEN;

ADULT; ANTIBODY TITER; ARTICLE; AUTOIMMUNE HEPATITIS; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; HLA SYSTEM; HUMAN; IMMUNE RESPONSE; IMMUNOFLUORESCENCE; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; TREATMENT PLANNING;

ADULT; ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; AUTOIMMUNE DISEASES; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HEPATITIS; HLA-DR ANTIGENS; HUMANS; MALE; MIDDLE AGED; MUSCLE, SMOOTH; PROGNOSIS;

EID: 0030758252     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018809431189     Document Type: Article

References (42)

1. Czaja AJ, Davis GL, Ludwig J, Baggenstoss AH, Taswell HF: Autoimmune features as determinants of prognosis in steroid-treated chronic active hepatitis of uncertain etiology. Gastroenterology 85:713-717, 1983
2. Czaja AJ: Natural history, clinical features, and treatment of autoimmune hepatitis. Semin Liver Dis 4:1-12, 1984
3. Johnson PJ, McFarlane IG, Alvarez F, Bianchi FB, Bianchi L, Burroughs A, Chapman RW, Czaja AJ, Desmet V, Edleston ALWF, Gerber MA, Hoofnagle JH, Kakumu S, MacSween RNM, Maddrey WC, Manns MP, Meyer zum Buschenfelde K-H, Mieli-Vergani G, Portmann BC, Reed WD, Schalm SW, Scheuer PJ, Toda G, Tsuji T, Tygstrup N, Vergani D, Zeniya M: Meeting report. International Autoimmune Hepatitis Group. Hepatology 18:998-1005, 1993
4. Czaja AJ, Manns MP: The validity and importance of subtypes of autoimmune hepatitis: A point of view. Am J Gastroenterol 90:1206-1211, 1995
5. Soloway RD, Summerskill WHJ, Baggenstoss AH, Schoenfield LJ: "Lupoid" hepatitis, a nonentity in the spectrum of chronic active liver disease. Gastroenterology 63:458-465, 1972
6. Czaja AJ: Autoimmune chronic active hepatitis-a specific entity? The negative argument. J Gastro-Hepatol 5:343-351, 1990
7. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB: Immunologic features and HLA associations in chronic viral hepatitis. Gastroenterology 108:157-164, 1995
8. Seeff LB: Drug-induced chronic liver disease, with emphasis on chronic active hepatitis. Semin Liver Dis 1:104-115, 1981
9. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB: Genetic predispositions and immunologic features in chronic liver diseases other than autoimmune hepatitis. J Hepatol 24:52-59, 1996
10. Czaja AJ, Carpenter HA: Validation of a scoring system for the diagnosis of autoimmune hepatitis. Dig Dis Sci 41:305-314, 1996
11. Wiesner RH, LaRusso NF, Ludwig J, Dickson ER: Comparison of the clinicopathologic features of primary sclerosing cholangitis and primary biliary cirrhosis. Gastroenterology 88:108-114, 1985
12. Czaja AJ, Nishioka M, Morshed SA, Hachiya T: Patterns of nuclear immunofluorescence and reactivities to recombinant nuclear antigens in autoimmune hepatitis. Gastroenterology 107:200-207, 1994
13. Czaja AJ: Autoantibodies. Bailliere's Clin Gastroenterol 9:723-744, 1995
14. White RH, Robbins DL: Clinical significance and interpretation of antinuclear antibodies. West J Med 147:210-213, 1987
15. Reimer G, Raska I, Tan EM, Scheer U: Human autoantibodies: Probes for nucleolus structure and function. Virchows Arch 854:131-143, 1987
16. Whittingham S, McNeilage LJ: Antinuclear antibodies as molecular and diagnostic probes. Mol Cell Probes 2:1169-179, 1988
17. Tan EM, Chan EKL, Sullivan KF, Rubin RL: Antinuclear antibodies (ANAs): Diagnostically specific immune markers and clues toward the understanding of systemic autoimmunity. Clin Immunol Immunopathol 47:121-141, 1988
18. Tan EM: Antinuclear antibodies: Diagnostic markers and clues to the basis of systemic autoimmunity. Pediatr Infect Dis 7:S3-S9, 1988
19. Sturgess A: Recently characterized autoantibodies and their clinical significance. Aust NZ J Med 22:279-289, 1992
20. Lassoued K, Brenard R, Degos F, Courvalin J-C, Andre C, Danon F, Brouet J-C, Zine-El-Abidine Y, Degott C, Zafrani S, Dhumeaux C, Benhamou J-P: Antinuclear antibodies directed to a 200-kilodalton polypeptide of the nuclear envelope in primary biliary cirrhosis. Gastroenterology 99:181-186, 1990
21. Fusconi M, Cassani F, Govoni M, Caselli A, Farbegoli F, Lenzi M, Ballardini G, Zauli D, Bianchi FB: Anti-nuclear antibodies of primary biliary cirrhosis recognize 78-92-kD and 96-100-kD proteins of nuclear bodies. Clin Exp Immunol 83:291-297, 1991
22. Summerskill WHJ, Korman MG, Ammon HV, Baggenstoss AH: Prednisone for chronic active liver disease: Dose titration, standard dose, and combination with azathioprine compared. Gut 16:876-883, 1975
23. Czaja AJ: Autoimmune hepatitis: Current therapeutic concepts. Clin Immunother 1:413-429, 1994
24. Czaja AJ: Autoimmune hepatitis: Evolving concepts and treatment strategies. Dig Dis Sci 40:435-456, 1995
25. Czaja AJ: Diagnosis and therapy of autoimmune liver disease. Med Clin North Am 80:973-994, 1996
26. Schalm SW, Korman MG, Summerskill WHJ, Czaja AJ, Baggenstoss AH: Severe chronic active liver disease: Prognostic significance of initial morphologic patterns. Am J Dig Dis 22:973-980, 1977
27. Czaja AJ, Carpenter HA: Sensitivity, specificity and predictability of biopsy interpretations in chronic hepatitis. Gastroenterology 105:1824-1832, 1993
28. Czaja AJ, Manns MP, Homburger HA: Frequency and significance of antibodies to liver/kidney microsome type 1 in adults with chronic active hepatitis. Gastroenterology 103:1290-1295, 1992
29. DiMagno EP, Corle D, O'Brien JF, Masnyk IJ, Go VLW, Aamodt R: Effect of long-term freezer storage, thawing, and refreezing on selected constituents of serum. Mayo Clin Proc 64:1226-1234, 1989
30. Cassani F, Bianchi FB, Lenzi M, Volta U, Pisi E: Immunomorphological characterization of antinuclear antibodies in chronic liver disease. J Clin Pathol 38:801-805, 1985
31. Tan EM: Autoantibodies to nuclear antigens: their immunology and meaning. Adv Immunol 33:167-240, 1982
32. Tan EM: Antinuclear antibodies. Diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 44:93-151, 1989
33. Bottazzo GF, Florin-Christensen A, Fairfax A, Swana G, Doniach D, Groeschel-Stewart U: Classification of smooth muscle autoantibodies (SMA) detected by immunofluorescence. J Clin Pathol 29:403-410, 1976
34. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB: Significance of HLA DR4 in type 1 autoimmune hepatitis. Gastroenterology 105:1502-1507, 1993
35. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB: Genetic predispositions for the immunological features of chronic active hepatitis. Hepatology 18:816-822, 1993
36. Bidwell JL, Bidwell EA, Savage DA, Middleton D, Klouda PT, Bradley BA: A DNA-RFLP typing system that positively identifies serologically well-defined and ill-defined HLA-DR and DQ alleles, including Drw10. Transplantation 45:640-646, 1988
37. Donaldson PT, Doherty DG, Hayllar KM, McFarlane IG, Johnson PJ, Williams R: Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors. Hepatology 13:701-706, 1991
38. Doherty DG, Donaldson PT, Underhill JA, Farrant JM, Duthie A, Mieli-Vergani G, McFarlane IG, Johnson PJ, Eddleston ALWF, Mowat AP, Williams R: Allelic sequence variation in the HLA class II genes and proteins in patients with autoimmune hepatitis. Hepatology 19:609-615, 1994
39. Czaja AJ, Strettel MDJ, Thomson LJ, Santrach PJ, Moore SB, Donaldson PT, Williams R: Associations between alleles of the major histocompalibility complex and type 1 autoimmune hepatitis. Hepatology 25:317-323, 1997
40. Czaja AJ, Pfeifer KD, Decker RH, Vallari AS: Frequency and significance of antibodies to asialoglyoprotein receptor in type 1 autoimmune hepatitis. Dig Dis Sci 41:1733-1740, 1996
41. Czaja AJ, Cassani F, Cataleta M, Valentini P, Bianchi FB: Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis. Hepatology 24:1068-1073, 1996
42. Czaja AJ, Santrach PJ, Moore SB: HLA DQ associations in type 1 autoimmune hepatitis. Mayo Clin Proc 70:1154-1160, 1995